Oasmia Pharmaceutical AB

June 24, 2010

NASDAQ OMX (NASDAQ:NDAQ) announced that Oasmia Pharmaceutical AB (OASM), a Small Cap company within the Biotech sector, today starts trading of its shares on the main market of NASDAQ OMX Stockholm. Oasmia is the twelfth company to list on NASDAQ OMX in Europe in 2010.
 

Oasmia Pharmaceutical AB is based in Sweden and was founded in 1999. Oasmia develops a new generation of pharmaceuticals with the emphasis on human and veterinary oncology, with a vision to improve treatments of severe diseases. Learn more about Oasmia »

 

Follow Oasmia's share information »
 

	Weine Nejdemo CFO of Oasmia Pharmaceutical AB, is welcomed to NASDAQ OMX Nordic by Jenny Rosberg Senior Vice President, NASDAQ OMX.
	Annette Ljungmark, Head of Accounting and Human Resources,  tolls the bell together with Weine Nejdemo.
	Weine Nejdemo recevies a frame with the first closed deal.
	Oasmia celebrating the first day of listing at NASDAQ OMX Nordic.

Equity Rights and Convertible loans
Market Notices
Corporate actions
Listings
Subcribe to upcoming listings
Webcasts
The Nordic list (XLS)
About NASDAQ OMX Nordic
Rules and regulations

Free annual reports service
Company News Service log in
NewsClient log in

Read the latest trading statistics and statistics archives on equities, derivatives and fixed income instruments traded on NASDAQ OMX Nordic market.
Go to statistics » (Link opens in new window).